Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5‐fluorouracil in patients with unresectable biliary tract tumors

200574 citationsJournal Article

Authors

Maurizio Cantore · Accademia di Belle Arti di Carrara

Andrea Mambrini · Accademia di Belle Arti di Carrara

Giammaria Fiorentini · Ospedale San Giuseppe

Carla Rabbi · Azienda Ospedaliera Carlo Poma

D. Zamagni · Azienda Ospedaliera Carlo Poma

Roberto Caudana · Azienda Ospedaliera Carlo Poma

C. Pennucci

Abstract

This novel combined locoregional and systemic chemotherapeutic regimen was found to be active and safe for patients with advanced biliary tract carcinoma.

Topics & Keywords

Cholangiocarcinoma and Gallbladder Cancer Studies Hepatocellular Carcinoma Treatment and Prognosis Gallbladder and Bile Duct Disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Cancer

Volume 103, Issue 7, pp. 1402-1407

DOI: 10.1002/cncr.20964

Field-Weighted Citation Impact: 4.36